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Idiopathic environmental intolerance (IEI),
also known as multiple chemical sensitivity
(MCS), is a clinical description for a cluster of
symptoms of unknown etiology that have been
attributed by patients to multiple environmen-
tal exposures when other medical explanations
have been excluded. There are no specific
physical or laboratory ﬁndings, and the diag-
nosis is usually one of exclusion. Consensus is
lacking with respect to IEI’s prevalence, diag-
nostic criteria, etiology, and therapeutic strate-
gies. There is substantial heterogeneity in
exposure, illness history, and presentation
among persons with this diagnosis (1–6). 
On average, IEI patients seen clinically are
between 40 and 50 years of age, with approxi-
mately 4 times as many women affected as
men. No single chemical or psychosocial situ-
ation has been deﬁned as more prevalent than
any other for the onset of symptoms (5).
Symptoms often include anxiety, lightheaded-
ness, impaired mentation, poor coordination,
breathlessness (without wheezing), tremor,
and abdominal discomfort (6). IEI patients
attribute these symptoms to various environ-
mental chemicals (3,6). 
Several hypotheses have been generated
regarding the mechanisms contributing to
IEI. A central question has been whether
individuals characterized with IEI suffer
from a toxic or allergic disorder or whether
psychological factors cause at least some to
develop physical symptoms that they
attribute to allergy or toxic mechanisms.
Because allergy has not been clearly demon-
strated and current toxicological paradigms
for exposure–symptom relationships do not
readily accommodate IEI, psychogenic theo-
ries have been the focus of a number of
investigations (7–9). 
Several investigators found increased
psychiatric morbidity among IEI patients
(7–12). Simon et al. (8) reported a greater
prevalence of current anxiety or depressive
disorders among patients with IEI than
among controls with chronic musculoskeletal
injuries. Black et al. (12) found a signiﬁcantly
higher lifetime prevalence of major depres-
sion, mood disorders, anxiety disorders, and
somatization disorder among patients with
environmental illness than among controls.
Fiedler et al. (11) compared psychiatric mor-
bidity among patients with IEI, chronic
fatigue syndrome (CFS), and healthy con-
trols. Current diagnoses of a major depressive
episode were significantly higher among IEI
and CFS patients than in controls. 
Panic Responses in Idiopathic
Environmental Intolerance
Evidence also suggests that panic responses
may play a role in the symptoms of IEI
patients (13,14). In a study by Leznoff (13),
11 of 15 IEI patients exposed to their pur-
ported trigger in an open fashion developed
hypocarbia and experienced their usual IEI
symptoms. In contrast, 4 of the 15 did not
develop hypocarbia or reproduce their
symptoms. The association of hypocarbia
with reproduction of symptoms suggested
that anxiety-driven hyperventilation result-
ing in hypocarbia may have contributed to
IEI symptom production. In a pilot study,
Binkley and Kutcher (10) reported that all
five IEI patients who were challenged with
intravenous sodium lactate infusion experi-
enced a symptomatic panic response. This is
a challenge shown to trigger panic attacks in
patients with panic disorder (PD) but not
in most normal controls (15). Independent
psychiatric assessment resulted in the diag-
nosis of PD on the basis of Diagnostic and
Statistical Manual of Mental Disorders
(DSM)-IV (16) criteria in each of the five
IEI patients (10). In response to this pilot
study, a larger study was performed by our
group (17) using inhaled carbon dioxide
(CO2) as a less invasive trigger to panic
(18,19). Inhaled CO2 has been shown to
trigger panic symptoms in 48–92% of
patients with PD and approximately 5% of
normal controls (20,21). In our study,
responses to a single-breath inhalation of
35% CO2 and a single breath of air alone
(delivered in a single-blind manner) were
compared in 36 subjects with IEI [fulfilling
criteria described by Simon et al. (8)] and
37 healthy controls. Subjects given a diag-
nosis of IEI were excluded from the study if
they had a previous psychiatric diagnosis or
were taking psychiatric medications.
Despite these exclusions, DSM-IV (16) cri-
teria for a panic attack were elicited after
CO2 inhalation in significantly more IEI
subjects than controls (71 vs. 26%, p <
0.001). In addition, IEI subjects scored sig-
nificantly higher than controls on the
Anxiety Sensitivity Index (ASI), a self-report
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Unexplained Symptoms
Idiopathic environmental intolerance (IEI), also known as multiple chemical sensitivity, is a clini-
cal description for a cluster of symptoms of unknown etiology that have been attributed by
patients to multiple environmental exposures when other medical explanations have been
excluded. Because allergy has not been clearly demonstrated and current toxicological paradigms
for exposure–symptom relationships do not readily accommodate IEI, psychogenic theories have
been the focus of a number of investigations. A signiﬁcantly higher lifetime prevalence of major
depression, mood disorders, anxiety disorders, and somatization disorder has been reported among
patients with environmental illness compared with that in controls. Symptoms often include anxi-
ety, lightheadedness, impaired mentation, poor coordination, breathlessness (without wheezing),
tremor, and abdominal discomfort. Responses to intravenous sodium lactate challenge or single-
breath inhalation of 35% carbon dioxide versus a similar breath inhalation of clean air have shown
a greater frequency of panic responses in subjects with IEI than in control subjects, although such
responses did not occur in all subjects. Preliminary genetic ﬁndings suggest an increased frequency
of a common genotype with panic disorder patients. The panic responses in a signiﬁcant propor-
tion of IEI patients opens a therapeutic window of opportunity. Patients in whom panic responses
may at least be a contributing factor to their symptoms might be responsive to intervention with
psychotherapy to enable their desensitization or deconditioning of responses to odors and other
triggers, and/or may be helped by anxiolytic medications, relaxation training, and counseling for
stress management. Key words: idiopathic environmental intolerance, multiple chemical sensitiv-
ity, panic response. Environ Health Perspect 110(suppl 4):669–671 (2002).
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questionnaire (22) completed by the study
subjects prior to their visit for air and CO2
challenges. The ASI measures the extent to
which people are fearful of the physical sen-
sations associated with arousal and anxiety.
People with PD have higher ASI scores than
people with other anxiety disorders and
normal controls (23). Among IEI subjects
who fulfilled panic attack criteria following
the CO2 challenge, the initial self-reported
questionnaires indicated a higher frequency
of panic attacks in the preceding month
(mean 2.1) compared with the other IEI
subjects (mean 0.1, p < 0.05) (17). 
The IEI subjects in this study also scored
significantly higher than controls on other
self-completed questionnaires for anxiety and
agoraphobia (24). These included the
Mobility Inventory for Agoraphobia (MI), a
self-report questionnaire in which individuals
rate the extent to which they avoid 26 com-
mon agoraphobic situations when they are
alone (MI-Alone) and when accompanied
(MI-Accompanied) (25,26). The MI has been
proven to be a sensitive measure of agorapho-
bia per se rather than a reflection of anxiety
disorders in general (25,26). Scores for IEI
subjects were significantly higher than those
for controls for agoraphobic indices (25) both
alone and accompanied, as well as on the
Agoraphobia Cognitions Questionnaire (27),
a questionnaire designed to measure thoughts
related to agoraphobia and the consequences
of panic. They also scored signiﬁcantly higher
on anxiety and stress subscales of the
Depression Anxiety Stress Scales (DASS)
(24), a self-report questionnaire designed to
measure dysphoric mood (depression sub-
scale), symptoms of fear and autonomic
arousal (anxiety subscale), and symptoms of
general nervousness and agitation (stress sub-
scale) (28,29). IEI subjects scored higher than
controls on the depression subscale of the
DASS as well, a difference that was marginally
signiﬁcant (24). The 22 IEI subjects who ful-
filled panic attack criteria after 35% CO2
inhalation had signiﬁcantly higher scores than
IEI subjects who did not panic on the MI-
Alone component of the MI, as well as the
depression subscale of the DASS.
Therefore, evidence from these studies
supports an association between panic symp-
toms and IEI. In addition there was a trend
to an increase in other psychiatric morbidity
consistent with other reports (7,8,12).
Further support for an association with panic
response comes from subsequent genetic
analyses of DNA samples taken from IEI sub-
jects (30). Samples from MCS subjects were
compared with those from normal controls
and showed the presence of the PD-associ-
ated cholecystokinin B receptor allele 7 in 9
of 22 (41%) subjects with MCS compared
with 2 of 22 in control subjects.
Implications 
In conjunction with other reports of psycho-
logical and psychiatric assessments in IEI
patients, our findings indicate that a signifi-
cant contribution to symptoms in these
patients occurs from psychological and/or
psychiatric disorders. Our studies have partic-
ularly demonstrated a contribution from
panic responses. Conditioning of physical
symptoms after neurotoxic exposure was sug-
gested by Bolla-Wilson and colleagues in
1988 (31). Such a response could represent a
learned or conditioned reﬂex response follow-
ing an initial physical or emotional traumatic
event, with subsequent extension to various
non-noxious stimuli. Such learned responses
were reported in patients by Dager et al. (32),
and by Shusterman et al. (33) after solvent or
other chemical exposures. Similarly, in an
experimental setting, Van den Bergh and col-
leagues (34) demonstrated that healthy sub-
jects can acquire somatic symptoms and
respiratory changes in response to non-nox-
ious odors when these odors are associated
with a physiological challenge that originally
caused these symptoms. The response to the
non-noxious odors could subsequently be
reduced in an extinction procedure, which
further supports the hypothesis that this was a
conditioned response. The same research
group (35) subsequently reported that the
learned symptoms could also be extended to
new odors, particularly in subjects with high
negative affectivity. For a classically condi-
tioned fear response to be extinguished would
require subsequent pairing of the conditioned
stimulus (e.g., a feared substance in the envi-
ronment) with safety (i.e., a lack of negative
consequences) (36). It is not uncommon for
patients with IEI to relate the initial onset of
symptoms to an accidental exposure to a sub-
stance with a strong odor, either at work or in
another setting. 
It could be argued that although no toxic
response has been demonstrated in these
patients, hypothetically it is possible that a
toxic central neural change may have been
induced by such an exposure in subjects.
Nevertheless, the preliminary genetic ﬁndings
in this disorder (30) are more supportive of
an underlying predisposition to panic
responses. Similarly, reports by Black and col-
leagues (37,38) suggest preceding psychiatric
morbidity in these patients as well as an
increased prevalence of psychiatric disease in
relatives of MCS patients, which further sug-
gests that this condition occurs in a psycho-
logically susceptible group of individuals. 
Although the responses of these patients
are similar to those of patients with PD, this
psychiatric diagnosis cannot be used in these
IEI patients, as the current diagnosis of PD in
the DSM-IV (16) stipulates that PD cannot be
diagnosed if responses occur secondary to a
particular trigger rather than spontaneously.
Therefore the history given by IEI patients
(that an environmental exposure always trig-
gers symptoms) would exclude a formal diag-
nosis of PD. Further studies, such as
investigation of neurotransmitters, that exam-
ine other outcome measures of panic responses
in IEI patients may be useful in the future. 
The panic responses in a significant
proportion of IEI patients open a therapeutic
window of opportunity. Patients who accept
that panic responses may be at least a con-
tributing factor to their symptoms might be
responsive to intervention with psychother-
apy to enable their desensitization (decondi-
tioning of responses to odors and other
triggers) and/or may be helped by anxiolytic
medications, relaxation training, and counsel-
ing for stress management. A response to
such intervention has been reported anecdo-
tally (39,40,41), although randomized,
placebo-controlled studies of such an
approach have not been reported. Indeed,
although panic responses were common in
the group of IEI subjects we studied, only 1
among the 26 study subjects who had panic
responses was agreeable to having a referral to
a psychiatrist or psychologist. Perhaps such
intervention may be more successfully
achieved in a less formal manner through the
family doctor, although again there are no
published studies of such an approach. 
Another possible implication of these ﬁnd-
ings relates to the prevention of IEI. If this
response results from a conditioned reﬂex after
an accidental exposure, it would be possibile
to prevent such responses by appropriately
intervening after traumatic events such as acci-
dental chemical exposures in the workplace, as
suggested by Shusterman and Dager (42). It
may be expected that early, accurate health
information and early medical assessment—
with reassurance when appropriate—work-
place changes to prevent further accidental
exposure, and accommodation of the worker’s
potential need to be gradually reintroduced to
the same work area could be helpful. 
Finally, panic responses to CO2 challenges
did not occur in all our IEI study subjects,
and it is certainly likely that other organic
and/or psychiatric disease also contributes to
symptoms in some or all patients with IEI.
Therefore, it continues to be important that
such patients have both a full medical and
psychiatric/psychologic assessment to identify
other contributing diseases that may respond
to speciﬁc treatment.
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